Journal: International Journal of Molecular Sciences

Article Title: Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl

doi: 10.3390/ijms22115559

Figure Lengend Snippet: GAA facilitates Aβ42 degradation in microglial cells. ( A ) BV2 cells were treated with Rog (10 µM), GLT, and GLP at the indicated concentrations in the presence of Aβ42 (2 µM) for 24 h, and intracellular Aβ42 levels were measured using ELISA. Rog vs. Control: p = 0.0016; GLT-10 vs. Control: p =0.0005; GLT-30 vs. Control: p = 0.001; n = 3. ( B ) Aβ42 uptake by BV2 was assessed by applying FITC-labeled Aβ42 (1 µM) to BV2 cells in the presence of Rog (10 µM) and GLT at the indicated concentrations for 24 h. Accumulation of the fluorophore was analyzed by flow cytometry. n = 3. ( C – E ) BV2 cells were treated with Rog (10 µM), GAA, GAD, and GAG, respectively, at the indicated concentrations in the presence of Aβ42 (2 µM) for 24 h, and intracellular Aβ42 levels were measured using ELISA. ( C ) Rog vs. Control: p = 0.0002; GAA-5 vs. Control: p = 0.0132; GAA-20 vs. Control: 0.0002; n = 3. ( D ) Rog vs. Control: p = 0.0021; n = 3. ( E ) Rog vs. Control: p = 0.0009; n = 3. ( F ) Uptake of Aβ42 by BV2 was assessed by applying FITC-labeled Aβ42 (1 µM) to BV2 cells in the presence of Rog (10 µM) and GAA at the indicated concentrations for 24 h, and accumulation of the fluorophore was analyzed by fluorescence signal 1-height (FL1-H) of flow cytometry. Results were normalized to total cellular protein level, and DMSO at 0.1% was used as the control. n = 3. n is the number of replicates (biological and technical) used for each of the described results. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. indicated control.

Article Snippet: The human Aβ42 enzyme-linked immunosorbent assay (ELISA) kit was purchase from Cusabio (Wuhan, China).

Techniques: Enzyme-linked Immunosorbent Assay, Control, Labeling, Flow Cytometry, Fluorescence

Journal: International Journal of Molecular Sciences

Article Title: Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl

doi: 10.3390/ijms22115559

Figure Lengend Snippet: GAA promotes Aβ42 elimination through the autophagy pathway in microglial cells. ( A ) BV2 cells were treated with GAA (20 µM), the indicated antagonists of ADEs (arachidonic acid at 80 µM, sacubitrilat at 50 µM, enalapril maleate at 50 µM), autophagosomes (EACC at 2 µM) and lysosomes (chloroquine at 20 µM), in the presence of Aβ42 (2 µM) for 24 h, and intracellular Aβ42 levels were measured by ELISA. GAA + EACC vs. GAA: p = 0.0122; GAA + Chl vs. GAA: p = 0.0075; n = 3. ( B ) BV2 cells were treated with GAA (20 µM) for the indicated periods of time, and whole cell proteins were collected for western blot. 6 h vs. 0 h: p = 0.0219; 12 h vs. 0 h: p = 0.0467; n = 3. ( C – E ) BV2 cells were treated with GAA (20 µM) for the indicated times, and expression of Atg5, Becn1 and Map1lc3b was analyzed by qRT-PCR. ( C ) 6 h vs. 0 h: p = 0.0075; 12 h vs. 0 h: p = 0.0002; 24 h vs. 0 h: p = 0.0069; n = 3. ( D ) 3 h vs. 0 h: p = 0.0015; 6 h vs. 0 h: p = 0.0007; 12 h vs. 0 h: p = 0.0006; 24 h vs. 0 h: p = 0.0017; n = 3. ( E ) 3 h vs. 0: p = 0.0086; 6 h vs. 0 h: p = 0.0001; 12 h vs. 0 h: p < 0.0001; 24 h vs. 0 h: p = 0.0286; n = 3. ( F ) BV2 cells were treated with GAA (20 µM), the indicated agonist of AKT/PI3K (recilisib at 20 µM) and EACC (2 µM) for 6 h, and whole cell proteins were collected for western blot. GAA vs. Control: p = 0.0288; GAA + Recilisib vs. GAA: p = 0.0004; n = 3. ( G ) BV2 cells were treated with GAA (20 µM), recilisib (20 µM) and EACC (2 µM), in the presence of Aβ42 (2 µM) for 24 h, and intracellular Aβ42 levels were measured by ELISA. DMSO at 0.1% was used as the control. GAA vs. Control: p = 0.0031; GAA + EACC vs. GAA: p = 0.0064; n = 3. n is the number of replicates (biological and technical) used for each of the described results. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs. indicated control.

Article Snippet: The human Aβ42 enzyme-linked immunosorbent assay (ELISA) kit was purchase from Cusabio (Wuhan, China).

Techniques: Enzyme-linked Immunosorbent Assay, Western Blot, Expressing, Quantitative RT-PCR, Control

Journal: International Journal of Molecular Sciences

Article Title: Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl

doi: 10.3390/ijms22115559

Figure Lengend Snippet: GAA activates the autophagy pathway through Axl. BV2 cells were ( A ) treated with GAA at the indicated concentrations for 6 h or ( B ) treated with GAA (20 µM) for the indicated periods of time, and whole cell proteins were collected for Western blot. ( A ) GAA-5 vs. DMSO: p = 0.0452; GAA-20 vs. DMSO: p = 0.0034; n = 3. ( B ) 6 h vs. 0 h: p = 0.0299; 12 h vs. 0 h: p = 0.0073; n = 3. ( C – F ) BV2 cells were pretreated with 0.1% DMSO or the indicated Axl antagonist (R428 at 5 µM) for 30 min, followed by administration of GAA (20 µM) and Aβ42 (2 µM) for 6 h. Whole cell proteins then were collected for Western blot. ( D ) Aβ42 + GAA vs. Aβ42: p <0.0001; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p < 0.0001; n = 3. ( E ) Aβ42 + GAA vs. Aβ42: p = 0.028; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0304; n = 3. ( F ) Aβ42 + GAA vs. Aβ42: p = 0.0247; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0009; n = 3. ( G – H ) BV2 cells were pretreated with R428 (5 µM) for 30 min, followed by administration of FITC-Aβ42 (1 μM) and GAA (20 µM) for 6 h, and cells were immunostained with LysoTracker Red. Representative images show the co-localization of Aβ42 and lysosomes (yellow). Scale bar: 50 µm. Aβ42 + GAA vs. Aβ42: p = 0.0469; Aβ42 + GAA + R428 vs. Aβ42 + GAA p = 0.0057; n = 4. ( I ) BV2 cells were pretreated with the indicated antagonists of Axl (R428 at 5 µM) and Pak1 (IPA-3 at 20 µM), followed by administration of GAA (20 µM) and Aβ42 (2 µM) for 24 h. The intracellular Aβ42 levels were measured by ELISA. DMSO at 0.1% was used as the control. GAA vs. Control: p = 0.0012; GAA + R428 vs. GAA: p = 0.0151; GAA + IPA vs. GAA: p = 0.0015; n = 3. n is the number of replicates (biological and technical) used for each of the described results. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs. indicated control.

Article Snippet: The human Aβ42 enzyme-linked immunosorbent assay (ELISA) kit was purchase from Cusabio (Wuhan, China).

Techniques: Western Blot, Enzyme-linked Immunosorbent Assay, Control

Journal: International Journal of Molecular Sciences

Article Title: Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl

doi: 10.3390/ijms22115559

Figure Lengend Snippet: GAA ameliorates Aβ42-induced behavioral deficits in Aβ-injected mice through Axl. ( A ) Experimental design for the animal study. Cerebroventricular injection of aggregated Aβ42 (82 pmol/µL, 5 µL/mouse) was applied to 8-week-old mice. ( B ) Representative motion track and ( C ) the discrimination index in the object recognition test. Aβ42 vs. Sham: p = 0.0019; Aβ42 + Rog vs. Aβ42: p = 0.0101; Aβ42 + GAA vs. Aβ42: p = 0.0038; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0078; n = 8 ( D ) Escape latency during spatial-acquisition training. (Day2) Aβ42 vs. Sham: p = 0.0011; Aβ42 + Rog vs. Aβ42: p = 0.0303; Aβ42 + GAA vs. Aβ42: p = 0.0304; n = 8. (Day3) Aβ42 vs. Sham: p = 0.0002; Aβ42 + Rog vs. Aβ42: p = 0.0019; Aβ42 + GAA vs. Aβ42: p = 0.0028; n = 8. (Day4) Aβ42 vs. Sham: p < 0.0001; Aβ42 + Rog vs. Aβ42: p < 0.0001; Aβ42 + GAA vs. Aβ42: p < 0.0001; n = 8. (Day5) Aβ42 vs. Sham: p = 0.0004; Aβ42 + Rog vs. Aβ42: p = 0.0002; Aβ42 + GAA vs. Aβ42: p = 0.0002; n = 8. ( E ) Representative motion track, ( F ) the platform-crossing number, (Aβ42 vs. Sham: p < 0.0001; Aβ42 + Rog vs. Aβ42: p < 0.0001; Aβ42 + GAA vs. Aβ42: p < 0.0001; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p < 0.0001; n = 8.) ( G ) distance in the target quadrant (Aβ42 vs. Sham: p < 0.0001; Aβ42 + Rog vs. Aβ42: p = 0.0004; Aβ42 + GAA vs. Aβ42 p < 0.0001; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0002; n = 8.) and ( H ) time spent in the target quadrant (Aβ42 vs. Sham: p = 0.0002; Aβ42 + Rog vs. Aβ42: p = 0.0002; Aβ42 + GAA vs. Aβ42: p =0.0003; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0001; n = 8.) in the spatial-probe test. ( I ) Aβ42 level in the hippocampus detected by ELISA. Aβ42 vs. Sham: p = 0.0014; Aβ42 + Rog vs. Aβ42: p = 0.0064; Aβ42 + GAA vs. Aβ42: p = 0.0266; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0053; n = 8. ( J ) LC3B level in the hippocampus detected by IHC assessment. Images were obtained under a microscope (scale bar: 100 μm). Aβ42 + GAA vs. Aβ42: p = 0.0004; Aβ42 + GAA + R428 vs. Aβ42 + GAA: p = 0.0009; n = 4. n is the number of replicates (biological and technical) used for each of the described results. ## p < 0.01, ### p < 0.001, #### p < 0.0001 vs. Sham group. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs. Aβ42 group ( n = 8 mice/ group).

Article Snippet: The human Aβ42 enzyme-linked immunosorbent assay (ELISA) kit was purchase from Cusabio (Wuhan, China).

Techniques: Injection, Enzyme-linked Immunosorbent Assay, Microscopy

Journal: Cell Reports

Article Title: Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis

doi: 10.1016/j.celrep.2020.108615

Figure Lengend Snippet:

Article Snippet: The human (6E10) Aβ42 ultra-sensitive electrochemiluminescent kit (Meso Scale Discovery) was used as per the manufacturers instructions.

Techniques: Recombinant, SYBR Green Assay, Expressing

Journal: Journal of Neuroinflammation

Article Title: Modulation of neuronal α1-adrenergic receptor reduces tauopathy and neuroinflammation by inhibiting the STING/NF-κB/NLRP3 signaling pathway in Alzheimer’s disease mice

doi: 10.1186/s12974-025-03506-3

Figure Lengend Snippet: Neuronal ADRA1 knockdown alleviates tauopathy and neuronal damage in 3xTg-AD mice. A Western blot analysis was conducted to assess the expression levels of p-Taus396, p-Tau202/205, p-Tau231 and Tau5 in the hippocampus tissue of the four group mice ( n = 6). Quantification analysis of p-Taus396 ( B ), p-Tau202/205 ( C ), p-Tau231 ( D ) and Tau5 ( E ) protein expression. F Western blot analysis of hippocampal APP and Aβ expression across groups ( n = 6). Quantification analysis of APP ( G ) and Aβ ( H ) protein expression. ELISA measurement of Aβ40 ( I ) and Aβ42 ( J ) protein levels ( n = 4). K Representative images Golgi-Cox-stained hippocampal neurons. L Sholl analysis of dendritic complexity ( n = 5 neurons from three mice per group). M Representative images of Golgi-stained dendritic spines in hippocampal regions. N Quantitative analysis of dendritic spine density ( n = 12 neurons from three mice per group). O Western blot analysis of hippocampal PSD95 and Snap25 expression across groups ( n = 6). Quantification analysis of PSD95 ( P ) and Snap25 ( Q ) protein expression. Data are expressed as mean ± SEM, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Article Snippet: Supernatants were collected from each experimental group and protein concentrations of IL-1β (E-EL-H0149 and E-EL-M0037, Elabscience), IL-6 (E-EL-H6156, Elabscience), IL-18 (E-EL-H0253 and E-EL-M0730, Elabscience), Aβ40 (E-EL-H0542, Elabscience) and Aβ42 (E-EL-H0543, Elabscience) were quantified using commercially available ELISA kits following the manufacturer's instructions.

Techniques: Knockdown, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Staining